-
Ganetespib radiosensitization for liver cancer therapy. Cancer Biology and Therapy. 17:457-466.
-
Intensity-modulated radiation therapy for anal cancer. Oncology. 24.
-
Automatic treatment planning implementation using a database of previously treated patients. Journal of Physics: Conference Series. 489.
-
Changes to physician processing times in response to clinic congestion and patient punctuality. BMJ Open. 6.
-
Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation. Practical Radiation Oncology. 2:77-85.
-
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy. Journal of Gastrointestinal Oncology. 4:343-351.
-
Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients with Unresectable Pancreatic Cancer. International Journal of Radiation Oncology Biology Physics. 94:571-579.
-
Computed tomography imaging assessment of postexternal beam radiation changes of the liver. Future Oncology. 12:2729-2739.
-
ACR appropriateness criteria® resectable stomach cancer. ONCOLOGY (United States). 29.
-
Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization. Contemporary Clinical Trials. 50:143-149.
-
Longer course of induction chemotherapy followed by chemoradiation favors better survival outcomes for patients with locally advanced pancreatic cancer. American Journal of Clinical Oncology: Cancer Clinical Trials. 39:18-26.
-
ACR appropriateness criteria® borderline and unresectable pancreas cancer. ONCOLOGY (United States). 30.
-
Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. HPB. 18:236-246.
-
Reliable detection of somatic mutations in fine needle aspirates of pancreatic cancer with next-generation sequencing. Annals of Surgery. 263:153-161.
-
Neoadjuvant chemoradiation followed by interstitial prostate brachytherapy for synchronous prostate and rectal cancer. Practical Radiation Oncology. 2.
-
Advances of stereotactic body radiotherapy in pancreatic cancer. Chinese Journal of Cancer Research. 27:349-357.
-
Preoperative endorectal brachytherapy in the treatment of locally advanced rectal cancer. Seminars in Colon and Rectal Surgery. 25:26-32.
-
A Tale of Two Systems. American Journal of Medical Quality. 31:279-280.
-
High-dose-rate intraoperative radiation therapy. Journal of Contemporary Brachytherapy. 6:99-105.
-
Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns. Oncotarget. 6:36903-36910.
-
Improving an electronic system for measuring PROs in routine oncology practice. Journal of Cancer Survivorship. 10:573-582.
-
Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer. Practical Radiation Oncology. 6:417-424.
-
Carcinoma of the Pancreas. 1397-1415.e7.
-
Assessing the Financial Burden Associated With Treatment Options for Resectable Pancreatic Cancer. Annals of Surgery.
-
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer. Annals of Surgical Oncology. 22:2352-2358.
-
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma. Annals of Surgery.
-
Liver metastases from pancreatic adenocarcinoma. 95-109.
-
Gastrointestinal stereotactic body radiation therapy requires detailed normal tissue planning to prevent long-term complications. Practical Radiation Oncology. 3:147-148.
-
Appropriate customization of radiation therapy for stage II and III rectal cancer. Practical Radiation Oncology.
-
Organizing a multidisciplinary clinic. Chinese Clinical Oncology. 3.
-
Browser based platform in maintaining clinical activities-use of the ipads in head and neck clinics. Journal of Physics: Conference Series. 489.
-
Stereotactic body radiotherapy for pancreatic cancer. Expert Review of Anticancer Therapy. 16:523-530.
-
The tolerance of gastrointestinal organs to stereotactic body radiation therapy. Journal of Gastrointestinal Oncology. 5:236-246.
-
Multidisciplinary care of patients with intrahepatic cholangiocarcinoma. Gastroenterology Research and Practice. 2015.
-
Comparison of quantitative Y-90 SPECT and non-time-of-flight PET imaging in post-therapy radioembolization of liver cancer. Medical Physics. 43:5779-5790.
-
Multidisciplinary management and the future of treatment in cholangiocarcinoma. Expert Opinion on Orphan Drugs. 4:255-267.
-
Phosphorus-32, a clinically available drug, inhibits cancer growth by inducing DNA double-strand breakage. PLoS One. 10.
-
Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer alliance for clinical trials in oncology trial A021101. JAMA Surgery. 151.
-
Foreword. Current Problems in Cancer. 37:258.
-
ACR Appropriateness Criteria®-Anal Cancer. Gastrointestinal Cancer Research. 7:4-14.
-
Adjuvant chemotherapy and radiation following PDD for pancreatic adenocarcinoma. American Journal of Hematology/ Oncology. 8.
-
Systematic review on the treatment of isolated local recurrence of pancreatic cancer after surgery; re-resection, chemoradiotherapy and SBRT. HPB.
-
Pancreatic cancer and FOLFIRINOX. Cancer Medicine. 4:853-863.
-
Radiation Therapy for Colorectal Adenocarcinoma. 185-200.
-
Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer. Cancer Discovery. 6:166-175.
-
Efficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous carcinoma of the pancreas. Journal of Gastrointestinal Oncology. 6:115-125.
-
A practical framework for patient care teams to prospectively identify and mitigate clinical hazards. Joint Commission Journal on Quality and Patient Safety. 35:72-81.
-
ACR appropriateness criteria® rectal cancer. ONCOLOGY (United States). 28.
-
What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcinoma?. Journal of Gastrointestinal Surgery. 19:841-847.
-
A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers. Gynecologic Oncology.
-
Primary Pancreatic Adenocarcinoma. 526-533.
-
Survival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors. JNCCN Journal of the National Comprehensive Cancer Network. 13:1225-1231.
-
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma. Annals of Surgical Oncology. 22:1100-1106.
-
Locally advanced, unresectable pancreatic cancer. Journal of Clinical Oncology. 34:2654-2667.
-
Predictors of improved survival for patients with retroperitoneal sarcoma. Surgery (United States). 160:1628-1635.
-
Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States. JAMA Surgery. 148:1095-1102.